CAS 1259519-18-0

Neratinib-d6

CAS: 1259519-18-0

Formel: C₃₀H₂₃D₆ClN₆O₃

Molekulargewicht: 563.09

Ref: 4Z-N-088015

Neratinib-d6

Kontrolliertes Produkt

CAS: 1259519-18-0

Applications Labelled Neratinib (N390090). An oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer. Antitumor agent.
References Vogel, C., et al.: J. Clin. Oncol., 20, 719 (2002), Ji, H., et al.: Cancer Cell., 9, 485 (2006), Sequist, L., et al.: Oncologist, 12, 325 (2007),

Formel: C₃₀H₂₃D₆ClN₆O₃

Farbe und Form: Neat

Molekulargewicht: 563.08

Ref: TR-N390092

Neratinib-d6

CAS: 1259519-18-0

Neratinib-d6 is a potent inhibitor of cancer cell growth and is used in the treatment of various types of cancer. It induces apoptosis, or programmed cell death, in cancer cells by inhibiting specific proteins that are required for their survival. This anticancer drug has been shown to be effective against a variety of tumors and is being studied for its potential use in treating other types of cancer as well. Neratinib-d6 is a medicinal inhibitor that works by blocking the action of certain enzymes involved in the cell cycle, such as Chinese hamster ovary kinase and human epidermal growth factor receptor 2 (HER2). It is also an analog of neratinib, which is another anticancer drug that has been approved for use in humans. Neratinib-d6 can be detected in urine samples, making it useful for monitoring patients undergoing treatment with this drug.

Formel: C₃₀H₂₉ClN₆O₃

Reinheit: Min. 95%

Molekulargewicht: 563.1 g/mol

Ref: 3D-JAC51918